12:00 AM
 | 
Jan 05, 2015
 |  BioCentury  |  Finance

Back for more

Tallying Vivo's recent exits as VC raises $428M for eighth fund

About three years after closing its last fund, Vivo Capital (formerly Vivo Ventures) has come back for more. The firm raised $428 million for an eighth fund, according to a December SEC filing.

Vivo invests primarily in U.S. therapeutics and medical device companies in late-stage development, and in revenue-generating healthcare companies in greater China, with some small investments in public therapeutics companies.

The firm closed a $375 million seventh fund in January 2012 and earmarked 40-50% of the fund for investments in China,...

Read the full 412 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >